Feds’ contract with Pfizer for Paxlovid has some surprises
(By Sydney Lupkin for NPR) The United States is spending about $530 for each 5-day course of Pfizer’s COVID-19 pill,
Read More
Health Care Redesign
Millions of Medicare Beneficiaries Use Prescription Drugs That Could Be Subject to Price Negotiation, But Build Back Better Act Provision Exempts Many Drugs With High Federal Spending
(By Juliette Cubanski, Nolan Sroczynski , and Tricia Neuman for Kaiser Family Foundation published January 27, 2022) The Build Back
Read MoreBillionaire Mark Cuban launches online pharmacy aimed at lowering generic drug prices
(By Joe Hernandez for NPR) Billionaire investor and Dallas Mavericks owner Mark Cuban has launched an online pharmacy for generic
Read MoreSenior Emergency Center
There are more than 280 accredited geriatric emergency departments in 41 states. The purpose of a geriatric emergency room is
Read MoreClinics Say California’s New Medicaid Drug Program Will Force Them to Cut Services
(By Samantha Young for Kaiser Health News) SACRAMENTO, Calif. — California’s sweeping new program to buy prescription drugs for its
Read MoreWhat is the Medicare Direct Contracting program?
What is the Medicare Direct Contracting pilot program? First, Medicare is administered either by traditional fee-for-service Medicare or Medicare Advantage.
Read More6 things to know about healthcare marketplace Sesame
(By Nick Moran for Becker’s Hospital Review) Direct-to-patient healthcare marketplace Sesame is aiming to cut care costs down by using direct
Read MoreNew federal rule requires health plans to report costs: 6 things to know
(By Ayla Ellison for Becker’s Hospital Review) The Biden administration issued an interim final rule Nov. 17 that requires health plans to report
Read MorePotential Costs and Impact of Health Provisions in the Build Back Better Act
(By Cynthia Cox, Robin Rudowitz, Juliette Cubanski, Karen Pollitz, MaryBeth Musumeci, Usha Ranji, Michelle Long, and Meredith Freed for Kaiser
Read MorePfizer agrees to license generic versions of its COVID-19 pill — in some countries
(By Bill Chappell for NPR) Pfizer has signed a licensing deal to allow dozens of lower-income countries to benefit from
Read More